MICHAEL SCHEURER to Antineoplastic Agents
This is a "connection" page, showing publications MICHAEL SCHEURER has written about Antineoplastic Agents.
Connection Strength
0.651
-
Clinical and demographic factors contributing to asparaginase-associated toxicities in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2022 12; 63(12):2948-2954.
Score: 0.425
-
DNA methylation of a novel PAK4 locus influences ototoxicity susceptibility following cisplatin and radiation therapy for pediatric embryonal tumors. Neuro Oncol. 2017 Oct 01; 19(10):1372-1379.
Score: 0.076
-
SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma. Cancer Med. 2015 Nov; 4(11):1679-86.
Score: 0.066
-
The influence of oxidative stress on symptom occurrence, severity, and distress during childhood leukemia treatment. Oncol Nurs Forum. 2014 Jul 01; 41(4):E238-47.
Score: 0.061
-
Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia. Cancer Cell. 2020 06 08; 37(6):867-882.e12.
Score: 0.023